LetterLetter
The Soluble Isoform of CTLA-4 Correlates with Interferon-α Activity in Systemic Lupus Erythematosus
LEKH N. DAHAL, ROBERT N. BARKER and FRANK J. WARD
The Journal of Rheumatology February 2020, 47 (2) 302-304; DOI: https://doi.org/10.3899/jrheum.190678
LEKH N. DAHAL
MRC Centre for Drug Safety Science, Institute of Translational Medicine, University of Liverpool, Liverpool;
PhDROBERT N. BARKER
PhD
FRANK J. WARD
PhD
REFERENCES
- 1.↵
- 2.↵
- Wei SC,
- Duffy CR,
- Allison JP
- 3.↵
- 4.↵
- 5.↵
- Lenschow DJ,
- Zeng Y,
- Thistlethwaite JR,
- Montag A,
- Brady W,
- Gibson MG,
- et al.
- 6.↵
- Dahal LN,
- Basu N,
- Youssef H,
- Khanolkar RC,
- Barker RN,
- Erwig LP,
- et al.
- 7.↵
- 8.↵
- Ronnelid J,
- Tejde A,
- Mathsson L,
- Nilsson-Ekdahl K,
- Nilsson B
- 9.↵
- 10.↵
- Wofsy D
In this issue
The Journal of Rheumatology
Vol. 47, Issue 2
1 Feb 2020
The Soluble Isoform of CTLA-4 Correlates with Interferon-α Activity in Systemic Lupus Erythematosus
LEKH N. DAHAL, ROBERT N. BARKER, FRANK J. WARD
The Journal of Rheumatology Feb 2020, 47 (2) 302-304; DOI: 10.3899/jrheum.190678